A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...

This was the stock's second consecutive day of losses.

Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

Shares of Waters Corp. slid 3.16% to $287.53 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.01% to 6,296.79 and Dow Jones ...

BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.

Waters Corp.'s $17.5B merger with BD Biosciences aims to double revenue but raises risks. Read here for an investment ...

Waters Corp. closed 29.90% below its 52-week high of $423.56, which the company reached on January 30th.

The BD business will be spun off and merged with a Waters subsidiary. Waters shares were down about 11% in early trading ...

Waters Corporation is merging with BD’s Biosciences and Diagnostic Solutions business in a $17.5 billion deal to expand its capabilities in life sciences and diagnostics.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Scientific instruments company Waters Corporation (NYSE:WAT) will be reporting earnings tomorrow morning. Here’s what to look for. Waters Corporation beat analysts’ revenue expectations by 1.9 ...